Target Price | €2.90 |
Price | €0.67 |
Potential |
334.13%
register free of charge
|
Number of Estimates | 2 |
2 Analysts have issued a price target MediGene AG 2026 .
The average MediGene AG target price is €2.90.
This is
334.13%
register free of charge
€3.80
468.86%
register free of charge
€2.00
199.40%
register free of charge
|
|
A rating was issued by 2 analysts: 2 Analysts recommend MediGene AG to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the MediGene AG stock has an average upside potential 2026 of
334.13%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Million € | 6.03 | 9.50 |
80.70% | 57.55% | |
EBITDA Margin | -249.25% | -142.49% |
711.88% | 42.83% |
2 Analysts have issued a sales forecast MediGene AG 2024 . The average MediGene AG sales estimate is
This results in the following potential growth metrics:
1 Analyst has issued an EBITDA forecast MediGene AG 2024 . The average MediGene AG EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
EV/Sales | negative |
Analyst | Rating | Action | Date |
---|---|---|---|
H.C. WAINWRIGHT & CO., LLC |
Locked
➜
Locked
|
Locked | Dec 15 2024 |
BAADER HELVEA EQUITY RESEARCH |
Locked
➜
Locked
|
Locked | Aug 29 2024 |
Analyst Rating | Date |
---|---|
Locked
H.C. WAINWRIGHT & CO., LLC:
Locked
➜
Locked
|
Dec 15 2024 |
Locked
BAADER HELVEA EQUITY RESEARCH:
Locked
➜
Locked
|
Aug 29 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.